Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patients (Q43764489)

26 November 2017

Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patients (English)

1 reference

26 November 2017

11

Masakazu Toi

1 reference

26 November 2017

6

Yoshiki Mikami

1 reference

26 November 2017

Niansong Qian

1

1 reference

26 November 2017

Takayuki Ueno

2

1 reference

26 November 2017

Nobuko Kawaguchi-Sakita

3

1 reference

26 November 2017

Masahiro Kawashima

4

1 reference

26 November 2017

Noriyuki Yoshida

5

1 reference

26 November 2017

Tomoko Wakasa

7

1 reference

26 November 2017

Masayuki Shintaku

8

1 reference

26 November 2017

Shigeru Tsuyuki

9

1 reference

26 November 2017

Takashi Inamoto

10

1 reference

26 November 2017

27 June 2011

1 reference

26 November 2017

1 reference

26 November 2017

102

1 reference

26 November 2017

1590-1596

1 reference

26 November 2017

8

1 reference

Update of evidence in chemotherapy for breast cancer

26 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Caveolin-1: a tumor-promoting role in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Role of caveolae and caveolins in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3). Transformation suppressor effects of adenovirus-mediated gene delivery of caveolin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Genetic ablation of caveolin-1 in mammary epithelial cells increases milk production and hyper-activates STAT5a signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Cancer-associated fibroblasts and tumor growth--bystanders turning into key players

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Is dysfunction of caveolin-1 a link between systemic sclerosis and breast cancer, opening a window on both etiologies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Multiple functions of caveolin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Caveolin-1 expression in human breast lobular cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Stromal cell expression of caveolin-1 predicts outcome in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Caveolin-1 expression in benign and malignant lesions of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Breast cancer by proxy: can the microenvironment be both the cause and consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Caveolin-1 inhibits anoikis and promotes survival signaling in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Caveolin-1: an ambiguous partner in cell signalling and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Caveolin-1 deficiency (-/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Mice with cav-1 gene disruption have benign stromal lesions and compromised epithelial differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling"

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Epidermal Growth Factor-stimulated Tyrosine Phosphorylation of Caveolin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01985.X

10.1111/J.1349-7006.2011.01985.X

21 January 2018

Identifiers

DOI

1 reference

release_rjhyxlqsczbbjaim2p3w25yqhy

26 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rjhyxlqsczbbjaim2p3w25yqhy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference